Abstract:Dear Editor, In a recent paper in Diseases of the Esophagus, Zhang and colleagues conclude that “The number of lymph node metastases influences survival and International Union Against Cancer tumor-nodemetastasis classification for esophageal squamous cell carcinoma.” However, in their subgroup of patients, the average lymph node yield (LNY) is less than 4 (1146 patients with 4270 LNs harvested), and the number is too low to appropriately evaluate the International Union Against Cancer (UICC) tumor– node–metastasis classification for esophageal cancer. The current UICC classification demands for six LNs for pathologic lymph node (pN) staging. It is considered that the minimal regional LNY of six LNs as recommended by the UICC for esophageal carcinoma is far too low to appropriately stage the disease. Based on an international study including 3651 patients, Peyre et al. concluded that the number of LNs removed is an independent predictor of survival after esophagectomy for cancer, and to maximize this survival benefit, a minimum of 23 regional LNs must be removed. In Dr Rizk’s analysis, a total of 4627 patients who had esophagectomy alone for esophageal cancer were identified from the Worldwide Esophageal Cancer Collaboration database. Optimum number of nodes that should be resected to maximize 5-year survival was determined by random forest multivariable regression. Rice et al. concluded that greater extent of lymphadenectomy was associated with increased survival for all patients with esophageal cancer except at extremes (TisN0M0 and 7 regional LNs positive for cancer) and welldifferentiated pN0M0 cancer; they also considered that maximum 5-year survival was modulated by T classification: Resecting 10 nodes for pT1, 20 for pT2, and 30 for pT3/T4 was recommended. Surveillance, Epidemiology and End Results data suggest that patients undergoing surgical resection for esophageal cancer should have at least 18 LNs removed. Recently, Jamieson et al. reviewed the role of lymphadenectomy in esophageal cancer, and it is considered that from a staging and theoretical oncologic point of view, extended lymphadenectomy is preferred. From the perspective of Dr Jamieson, the role of LNY was also highlighted. Although the effect of the number of positive LNs was analyzed, the LNY is not enough to reflect the LN status of the patients in the paper by Zhang and colleagues, and the authors did not discuss the effect of LNY on the staging of esophageal cancer, so we have outlined the issue here.

Prognostic Significance of the Number of Lymph Nodes Examined in Node-Negative Siewert Type II Esophagogastric Junction Adenocarcinoma.

The Relationship Between the Number of Examined Lymph Nodes and the Efficacy of Chemotherapy for Gastric Cancer

Prognostic significance of the number of dissected lymph nodes in Siewert typeⅡadenocarcinoma of the esophagogastric junction without lymphatic metastasis

Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction

Prognostic Significance of Preoperative Lymph Node Assessment for Patients with Stage Pn0 Esophageal Squamous Cell Carcinoma after Esophagectomy.

Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.

The prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis after esophagectomy

Postoperative Survival Effect of Examined Lymph Node Count in Node-Negative Esophageal Carcinoma

Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG)

Risk Factors and Clinical Significance of Lower Perigastric Lymph Node Metastases in Siewert Type II and III Esophagogastric Junction Adenocarcinoma: a Retrospective Cohort Study

Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0

Prognostic Value of Lymph Node Evaluation in Stage II Small Bowel Adenocarcinoma: An Updated Analysis of Surveillance, Epidemiology, and End Results Database

Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.

Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients

The Prognostic Relevance of Parapyloric Lymph Node Metastasis in Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction

Log Odds of Positive Lymph Nodes Predicts Survival in Patients after Resection for Esophageal Cancer.

Association of the Number of Dissected Lymph Node (LN) with the Survivals of Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC) Patients Received Preoperative Chemoradiotherapy (CRT) Followed by Surgery.

Effect of the Number of Positive Lymph Nodes and Lymph Node Ratio on Prognosis of Patients after Resection of Pancreatic Adenocarcinoma

Prognostic Significance of the Number of Removed Lymph Nodes in Pathologic Node-Negative Non-small Cell Lung Cancer

Prognostic Importance of Numbers of Retrieved Lymph Nodes and Positive Lymph Nodes for Ampulla of Vater Cancer (AVC) in 2347 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database.

The Number of Lymph Node Metastases Influences Survival and International Union Against Cancer Tumor-Node-metastasis Classification for Esophageal Squamous Cell Carcinoma: Does Lymph Node Yield Matter?